Delivery Order SPE2DB20D3103-SPE2DB25FN0S8
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,675.40 firm fixed-price contract is for the supply of 100 units of the medication VYVANSE 30 MG CAPSULE. The contract has a completion date of January 22, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,927.20 firm-fixed-price contract is for the delivery of 4,565,638,359 units of the prescription drug VYVANSE 30 MG CAPSULE 100S. The order has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,566,196,313 units of VYVANSE CAPS 30MG, a prescription medication. The contract has a firm fixed price of $13,819.32 and a completion date of October 25, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,343.49 firm fixed-price delivery order is for the supply of 4,563,886,982 units of VYVANSE 10 MG CAPSULE 100S. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.63 firm fixed-price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,902.66 Firm Fixed Price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4,566,178,875 units of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, for a firm fixed price of $2,367.08. The award has an ultimate completion date of October 23, 2024. This delivery order is part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,265,916 units of the medication VYVANSE 10 MG CAPSULE 100S, with a ceiling value of $1,320.90. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) with a period of performance through July 29, 2024. Amerisourcebergen is not operating under a set-aside designation for this award. This delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,358.10 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567410765 VYVANSE 30 MG CAPSULE 100S and has a completion date of February 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,675.40 firm fixed-price contract is for the delivery of 4567221232 VYVANSE 10 MG CAPSULE 100S, a specialty medication. The award has a completion date of February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...